Scage Future Faces Nasdaq Compliance Challenge
Scage Future's stock price surged by 65.36% as it crossed above the 5-day SMA, despite the Nasdaq-100 and S&P 500 showing declines.
The company received a compliance notification from Nasdaq regarding its failure to meet the minimum bid price requirement of $1.00 per share, as its shares traded below this threshold for 30 consecutive days. Scage Future has been granted a 180-day grace period to regain compliance, although this notification has not impacted its operations. The company is exploring options such as a reverse stock split to address the compliance issue.
This situation highlights the challenges Scage Future faces in maintaining investor confidence while it continues to focus on its mission of decarbonizing global transportation through innovative technologies.
Trade with 70% Backtested Accuracy
Analyst Views on SCAG
About SCAG
About the author
Scage Future Faces Nasdaq Warning Over Minimum Bid Price
- Nasdaq Warning: Scage Future (SCAG) announced on Thursday that Nasdaq notified the company of its failure to meet the $1 minimum bid price requirement after its ADSs traded below this threshold for 30 consecutive business days, which may impact investor confidence.
- Compliance Deadline: The company has 180 days to regain compliance by maintaining a share price above $1 for at least 10 consecutive business days, a requirement that will compel the company to take measures to avoid potential delisting risks.
- Possible Responses: If compliance is not restored, Scage Future may seek additional time or consider a reverse stock split, which could affect shareholder equity and the company's market image.
- Stock Price Reaction: Following the announcement, Scage Future's stock traded approximately 6.86% lower in after-hours trading at around $0.35, reflecting market concerns regarding the company's ability to regain compliance.
Scage Future Faces Nasdaq Compliance Challenge
- Compliance Notification: Scage Future received a notification from Nasdaq on June 11, 2026, indicating non-compliance with the minimum bid price requirement of $1.00 per share, as its ordinary shares failed to meet this threshold for 30 consecutive trading days.
- Grace Period: The company has been granted a 180-day grace period to regain compliance; failure to achieve a closing bid price of at least $1.00 for 10 consecutive trading days may lead to delisting, although its current listing status remains unaffected.
- Operational Impact: The receipt of the compliance notification has not impacted the company's operations, and Scage Future plans to monitor its ordinary share prices while considering options such as a reverse stock split to regain compliance.
- Market Outlook: As a leading zero-emission technology provider in China, Scage Future is committed to decarbonizing global commercial transportation through its advanced heavy-duty NEVs and innovative e-fuel systems, highlighting its strategic significance in the sustainable transport sector.
Fonar Corp (FONR) Signs Definitive Agreement for Take-Private Sale, Shares Surge 24.5%
- Take-Private Agreement Signed: Fonar Corp announced the signing of a definitive agreement for a take-private sale, resulting in a 24.5% surge in pre-market shares to $18.25, indicating strong market confidence that could provide financial backing for future growth.
- Strong Market Reaction: The stock's robust performance in pre-market trading reflects optimistic investor sentiment regarding the privatization deal, potentially attracting more investor interest and enhancing the company's overall market capitalization.
- Significant Industry Impact: Fonar's privatization move may trigger similar actions among other medical device companies, prompting more firms in the sector to consider privatization to enhance operational efficiency and shareholder value.
- Future Strategic Direction: By going private, Fonar is expected to concentrate resources on its core business and optimize its operational model, thereby strengthening its market position and profitability in a highly competitive healthcare market.
Intuit Shares Rise: 20 Stocks Making Moves in Premarket Trading
Intuit's Financial Performance: Intuit Inc. reported better-than-expected first-quarter results, with revenue of approximately $3.89 billion and adjusted earnings of $3.34 per share, leading to a 3.2% increase in share price during pre-market trading.
Second-Quarter Expectations: The company anticipates second-quarter revenue growth of 14% to 15% and adjusted earnings between $3.63 and $3.68 per share, which is below analyst estimates.
Pre-Market Stock Movements: Several stocks saw significant pre-market trading movements, including Nuvve Holding Corp, which surged 49.4%, and Enviri Corp, which gained 31.5% after announcing a major sale.
Declines in Other Stocks: Conversely, Pasithea Therapeutics Corp experienced a notable decline of 25.3% following the release of interim trial data, alongside other stocks like Safe & Green Holdings Corp and VisionSys AI Inc, which also saw significant drops.
Teradyne Shares Surge Over 20%; Check Out 20 Stocks Making Moves in Premarket Trading
Teradyne's Strong Performance: Teradyne Inc. shares surged 20.7% in pre-market trading after reporting third-quarter earnings of 85 cents per share, exceeding analyst expectations of 79 cents, along with sales of $769.210 million, surpassing the $743.776 million estimate.
Notable Gainers: Several stocks saw significant pre-market gains, including Profusa Inc. (+72.8%), Founder Group Ltd (+59.4%), and Vsee Health Inc. (+44.3%), driven by positive developments such as manufacturing capacity increases and regulatory approvals.
Major Losers: Stride Inc. experienced a sharp decline of 36.4% after providing disappointing sales guidance, while Varonis Systems Inc. and Akebia Therapeutics Inc. also fell significantly due to lower-than-expected revenue and trial design issues, respectively.
Market Overview: The pre-market trading session showed a mix of gains and losses across various stocks, with notable movements in both directions, reflecting investor reactions to earnings reports and company announcements.
New Fortress Energy Reports Q2 Loss, Alongside Summit Therapeutics and Other Major Stocks Declining in Monday's Pre-Market Trading
U.S. Stock Futures: U.S. stock futures rose this morning, with Nasdaq futures increasing by approximately 100 points, despite some stocks experiencing significant declines in pre-market trading.
New Fortress Energy Results: New Fortress Energy Inc. reported a quarterly adjusted loss of $2.02 per share, leading to a 12.5% drop in its shares to $2.14 in pre-market trading.
Other Declining Stocks: Several other stocks also fell in pre-market trading, including CNFinance Holdings Limited (-18.8%), Summit Therapeutics Inc. (-17%), and Sono Group N.V. (-15%).
Market Overview: The overall market showed mixed signals, with various companies experiencing notable declines, indicating volatility in the stock market ahead of upcoming investor events.
Scage Future Faces Nasdaq Warning Over Minimum Bid Price
- Nasdaq Warning: Scage Future (SCAG) announced on Thursday that Nasdaq notified the company of its failure to meet the $1 minimum bid price requirement after its ADSs traded below this threshold for 30 consecutive business days, which may impact investor confidence.
- Compliance Deadline: The company has 180 days to regain compliance by maintaining a share price above $1 for at least 10 consecutive business days, a requirement that will compel the company to take measures to avoid potential delisting risks.
- Possible Responses: If compliance is not restored, Scage Future may seek additional time or consider a reverse stock split, which could affect shareholder equity and the company's market image.
- Stock Price Reaction: Following the announcement, Scage Future's stock traded approximately 6.86% lower in after-hours trading at around $0.35, reflecting market concerns regarding the company's ability to regain compliance.
Scage Future Faces Nasdaq Compliance Challenge
- Compliance Notification: Scage Future received a notification from Nasdaq on June 11, 2026, indicating non-compliance with the minimum bid price requirement of $1.00 per share, as its ordinary shares failed to meet this threshold for 30 consecutive trading days.
- Grace Period: The company has been granted a 180-day grace period to regain compliance; failure to achieve a closing bid price of at least $1.00 for 10 consecutive trading days may lead to delisting, although its current listing status remains unaffected.
- Operational Impact: The receipt of the compliance notification has not impacted the company's operations, and Scage Future plans to monitor its ordinary share prices while considering options such as a reverse stock split to regain compliance.
- Market Outlook: As a leading zero-emission technology provider in China, Scage Future is committed to decarbonizing global commercial transportation through its advanced heavy-duty NEVs and innovative e-fuel systems, highlighting its strategic significance in the sustainable transport sector.
Fonar Corp (FONR) Signs Definitive Agreement for Take-Private Sale, Shares Surge 24.5%
- Take-Private Agreement Signed: Fonar Corp announced the signing of a definitive agreement for a take-private sale, resulting in a 24.5% surge in pre-market shares to $18.25, indicating strong market confidence that could provide financial backing for future growth.
- Strong Market Reaction: The stock's robust performance in pre-market trading reflects optimistic investor sentiment regarding the privatization deal, potentially attracting more investor interest and enhancing the company's overall market capitalization.
- Significant Industry Impact: Fonar's privatization move may trigger similar actions among other medical device companies, prompting more firms in the sector to consider privatization to enhance operational efficiency and shareholder value.
- Future Strategic Direction: By going private, Fonar is expected to concentrate resources on its core business and optimize its operational model, thereby strengthening its market position and profitability in a highly competitive healthcare market.
Intuit Shares Rise: 20 Stocks Making Moves in Premarket Trading
Intuit's Financial Performance: Intuit Inc. reported better-than-expected first-quarter results, with revenue of approximately $3.89 billion and adjusted earnings of $3.34 per share, leading to a 3.2% increase in share price during pre-market trading.
Second-Quarter Expectations: The company anticipates second-quarter revenue growth of 14% to 15% and adjusted earnings between $3.63 and $3.68 per share, which is below analyst estimates.
Pre-Market Stock Movements: Several stocks saw significant pre-market trading movements, including Nuvve Holding Corp, which surged 49.4%, and Enviri Corp, which gained 31.5% after announcing a major sale.
Declines in Other Stocks: Conversely, Pasithea Therapeutics Corp experienced a notable decline of 25.3% following the release of interim trial data, alongside other stocks like Safe & Green Holdings Corp and VisionSys AI Inc, which also saw significant drops.
Teradyne Shares Surge Over 20%; Check Out 20 Stocks Making Moves in Premarket Trading
Teradyne's Strong Performance: Teradyne Inc. shares surged 20.7% in pre-market trading after reporting third-quarter earnings of 85 cents per share, exceeding analyst expectations of 79 cents, along with sales of $769.210 million, surpassing the $743.776 million estimate.
Notable Gainers: Several stocks saw significant pre-market gains, including Profusa Inc. (+72.8%), Founder Group Ltd (+59.4%), and Vsee Health Inc. (+44.3%), driven by positive developments such as manufacturing capacity increases and regulatory approvals.
Major Losers: Stride Inc. experienced a sharp decline of 36.4% after providing disappointing sales guidance, while Varonis Systems Inc. and Akebia Therapeutics Inc. also fell significantly due to lower-than-expected revenue and trial design issues, respectively.
Market Overview: The pre-market trading session showed a mix of gains and losses across various stocks, with notable movements in both directions, reflecting investor reactions to earnings reports and company announcements.
New Fortress Energy Reports Q2 Loss, Alongside Summit Therapeutics and Other Major Stocks Declining in Monday's Pre-Market Trading
U.S. Stock Futures: U.S. stock futures rose this morning, with Nasdaq futures increasing by approximately 100 points, despite some stocks experiencing significant declines in pre-market trading.
New Fortress Energy Results: New Fortress Energy Inc. reported a quarterly adjusted loss of $2.02 per share, leading to a 12.5% drop in its shares to $2.14 in pre-market trading.
Other Declining Stocks: Several other stocks also fell in pre-market trading, including CNFinance Holdings Limited (-18.8%), Summit Therapeutics Inc. (-17%), and Sono Group N.V. (-15%).
Market Overview: The overall market showed mixed signals, with various companies experiencing notable declines, indicating volatility in the stock market ahead of upcoming investor events.
